TY - JOUR
T1 - Advancing the use of noncoding RNA in regulatory toxicology: Report of an ECETOC workshop
AU - Aigner, Achim
AU - Buesen, Roland
AU - Gant, Tim
AU - Gooderham, Nigel
AU - Greim, Helmut
AU - Hackermuller, Jorg
AU - Hubesch, Bruno
AU - Laffont, Madeleine
AU - Marczylo, Emma
AU - Meister, Gunter
AU - Petrick, Jay S.
AU - Rasoulpour, Reza J.
AU - Sauer, Ursula G.
AU - Schmidt, Kerstin
AU - Seitz, Herve
AU - Slack, Frank
AU - Sukata, Tokuo
AU - van der Vies, Saskia M.
AU - Verhaert, Jan
AU - Witwer, Kenneth W.
AU - Poole, Alan
PY - 2016/12
Y1 - 2016/12
N2 - The European Centre for the Ecotoxicology and Toxicology of Chemicals (ECETOC) organised a workshop to discuss the state-of-the-art research on noncoding RNAs (ncRNAs) as biomarkers in regulatory toxicology and as analytical and therapeutic agents. There was agreement that ncRNA expression profiling data requires careful evaluation to determine the utility of specific ncRNAs as biomarkers. To advance the use of ncRNA in regulatory toxicology, the following research priorities were identified: (1) Conduct comprehensive literature reviews to identify possibly suitable ncRNAs and areas of toxicology where ncRNA expression profiling could address prevailing scientific deficiencies. (2) Develop consensus on how to conduct ncRNA expression profiling in a toxicological context. (3) Conduct experimental projects, including, e.g., rat (90-day) oral toxicity studies, to evaluate the toxicological relevance of the expression profiles of selected ncRNAs. Thereby, physiological ncRNA expression profiles should be established, including the biological variability of healthy individuals. To substantiate the relevance of key ncRNAs for cell homeostasis or pathogenesis, molecular events should be dose-dependently linked with substance-induced apical effects. Applying a holistic approach, knowledge on ncRNAs, ‘omics and epigenetics technologies should be integrated into adverse outcome pathways to improve the understanding of the functional roles of ncRNAs within a regulatory context.
AB - The European Centre for the Ecotoxicology and Toxicology of Chemicals (ECETOC) organised a workshop to discuss the state-of-the-art research on noncoding RNAs (ncRNAs) as biomarkers in regulatory toxicology and as analytical and therapeutic agents. There was agreement that ncRNA expression profiling data requires careful evaluation to determine the utility of specific ncRNAs as biomarkers. To advance the use of ncRNA in regulatory toxicology, the following research priorities were identified: (1) Conduct comprehensive literature reviews to identify possibly suitable ncRNAs and areas of toxicology where ncRNA expression profiling could address prevailing scientific deficiencies. (2) Develop consensus on how to conduct ncRNA expression profiling in a toxicological context. (3) Conduct experimental projects, including, e.g., rat (90-day) oral toxicity studies, to evaluate the toxicological relevance of the expression profiles of selected ncRNAs. Thereby, physiological ncRNA expression profiles should be established, including the biological variability of healthy individuals. To substantiate the relevance of key ncRNAs for cell homeostasis or pathogenesis, molecular events should be dose-dependently linked with substance-induced apical effects. Applying a holistic approach, knowledge on ncRNAs, ‘omics and epigenetics technologies should be integrated into adverse outcome pathways to improve the understanding of the functional roles of ncRNAs within a regulatory context.
KW - Noncoding RNA (ncRNA)
KW - Regulatory toxicology
KW - Biomarker
KW - Gene expression
KW - Phenotypic consequence
KW - Adverse-outcome-pathway
U2 - 10.1016/j.yrtph.2016.09.018
DO - 10.1016/j.yrtph.2016.09.018
M3 - Article
C2 - 27663666
SN - 0273-2300
VL - 82
SP - 127
EP - 139
JO - Regulatory Toxicology and Pharmacology
JF - Regulatory Toxicology and Pharmacology
ER -